Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T13:10:21.824Z.
Calculation as of: 2026-10-06T13:10:21.824Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$2.03B
PS Ratio
2.75
TTM Avg
2.17
3Y Avg
1.46
5Y Avg
1.19
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | $1.95B | N/A | N/A | N/A | N/A |
| Allient Inc. (ALNT)vs › | $2.02B | 3.51 | 2.23 | 1.32 | 1.25 |
| Allegiant Travel Company (ALGT)vs › | $2.02B | 0.70 | 0.60 | 0.50 | 0.77 |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.03B | N/A | N/A | N/A | N/A |
| Preformed Line Products Company (PLPC)vs › | $2.03B | 2.75 | 2.17 | 1.46 | 1.19 |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.86B | 2.93 | 3.19 | 3.45 | 3.02 |
| Cimpress plc (CMPR)vs › | $1.85B | 0.50 | 0.57 | 0.57 | 0.53 |
| Werner Enterprises, Inc. (WERN)vs › | $2.05B | 0.63 | 0.68 | 0.69 | 0.79 |
| Trinity Industries, Inc. (TRN)vs › | $2.10B | 1.03 | 1.18 | 0.94 | 1.15 |
| Hub Group, Inc. (HUBG)vs › | $1.74B | 0.47 | 0.66 | 0.63 | 0.60 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute